164 related articles for article (PubMed ID: 20597958)
1. Experiencing genetic counselling for hereditary cancers: the client's perspective.
Mendes AF; Santos TA; Sousa L
Eur J Cancer Care (Engl); 2011 Mar; 20(2):204-11. PubMed ID: 20597958
[TBL] [Abstract][Full Text] [Related]
2. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
Raymond VM; Everett JN
Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
4. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
[TBL] [Abstract][Full Text] [Related]
5. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
[TBL] [Abstract][Full Text] [Related]
6. [Genetic counselling in monogenic cancer syndromes].
Brøndum-Nielsen K; Gerdes AM
Ugeskr Laeger; 2006 Jun; 168(24):2350-4. PubMed ID: 16822419
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
9. Hereditary breast cancer. Psychosocial issues and family physicians' role.
Carroll JC; Heisey RE; Warner E; Goel V; McCready DR
Can Fam Physician; 1999 Jan; 45():126-32. PubMed ID: 10889865
[TBL] [Abstract][Full Text] [Related]
10. Hereditary cancers in children and ethical and psychosocial implications.
MacDonald DJ; Lessick M
J Pediatr Nurs; 2000 Aug; 15(4):217-25. PubMed ID: 10969494
[TBL] [Abstract][Full Text] [Related]
11. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
12. Hereditary melanoma and predictive genetic testing: why not?
Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer.
Taylor KM; Kelner MJ
CMAJ; 1996 Apr; 154(8):1155-8. PubMed ID: 8612250
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
Metcalfe A; Werrett J; Burgess L; Clifford C
Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
[TBL] [Abstract][Full Text] [Related]
15. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
[TBL] [Abstract][Full Text] [Related]
16. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
[TBL] [Abstract][Full Text] [Related]
17. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
Lewis MJ; Peterson SK
Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
[TBL] [Abstract][Full Text] [Related]
18. How families communicate about HNPCC genetic testing: findings from a qualitative study.
Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
20. Hereditary cancer syndromes of the skin.
Somoano B; Niendorf KB; Tsao H
Clin Dermatol; 2005; 23(1):85-106. PubMed ID: 15708293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
